Cavitary pulmonary tuberculosis with COVID-19 coinfection
Zohaib Yousaf,
Adeel A. Khan,
Haseeb A. Chaudhary,
Kamran Mushtaq,
Jabeed Parengal,
Mohamad Aboukamar,
Muhammad Umair Khan,
Mouhand F.H. Mohamed
Affiliations
Zohaib Yousaf
Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Dresden International University, Dresden, (DIU), Germany; Corresponding author at: Department of Medicine, Hamad Medical Corporation, Doha, Qatar.
Adeel A. Khan
Department of Medicine, Hamad Medical Corporation, Doha, Qatar
Haseeb A. Chaudhary
Medicine, Reading Hospital, Tower Health Medical Group, West Reading, United States
Kamran Mushtaq
Dresden International University, Dresden, (DIU), Germany; Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
Jabeed Parengal
Department of Infectious Disease, Hamad Medical Corporation, Qatar
Mohamad Aboukamar
Department of Infectious Disease, Hamad Medical Corporation, Qatar
Muhammad Umair Khan
Dresden International University, Dresden, (DIU), Germany; Department of Gastroenterology and Hepatology, Hamad Medical Corporation, Doha, Qatar
Mouhand F.H. Mohamed
Department of Medicine, Hamad Medical Corporation, Doha, Qatar; Dresden International University, Dresden, (DIU), Germany
The COVID-19 pandemic has strained the healthcare system worldwide, leading to an approach favoring judicious resource allocation. A focus on resource preservation can result in anchoring bias and missed concurrent diagnosis. Coinfection of Mycobacterium tuberculosis (TB) and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has implications beyond morbidity at the individual level and can lead to unintended TB exposure to others. We present six cases of COVID-19 with newly diagnosed cavitating pulmonary tuberculosis to highlight the significance of this phenomenon and favorable outcomes if recognized early.
